{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:50:34Z","timestamp":1791424234091,"version":"4.3.3"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T00:00:00Z","timestamp":1144713600000},"content-version":"vor","delay-in-days":1926,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> Both \u03bc\u2010 and \u03b4\u2010opioid receptors have been implicated in the reinforcing actions of ethanol. However, selective opioid receptor antagonists have not altered ethanol intake in all rodent strains consistently, which suggests that genotype may modulate their suppressive effects. Therefore, we tested the effects of the selective \u03bc\u2010antagonist D\u2010Pen\u2010Cys\u2010Tyr\u2010D\u2010Trp\u2010Orn\u2010Thr\u2010Pen\u2010Thr\u2010NH<jats:sub>2<\/jats:sub>(CTOP) and the selective \u03b4\u2010antagonist naltrindole in both high\u2010drinking AA (Alko, Alcohol) and heterogeneous Wistar rats.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> AA and Wistar rats were trained to respond for ethanol (10% w\/v) in a two\u2010lever operant condition by using a saccharin fading procedure. After stable baseline responding was established, rats were implanted stereotaxically either with a guide cannula above the lateral ventricle or with bilateral cannulas above the nucleus accumbens, basolateral amygdala, or ventral tegmental area. After postoperative recovery, AA and Wistar animals were tested after intracerebroventricular microinjections of either CTOP (0\u20133 \u03bcg) or naltrindole (0\u201330 \u03bcg) or subcutaneous injections of naloxone (0\u20131 g\/kg), which was used as a reference antagonist. Effects of intracerebral microinjections of CTOP and naltrindole (both 0\u2013500 ng) were tested only in Wistar rats.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Subcutaneous naloxone and intracerebroventricular CTOP and naltrindole suppressed ethanol self\u2010administration in a similar manner in AA and Wistar rats. Cumulative response patterns indicated that naloxone and naltrindole had no effect on the initiation of responding but suppressed it later during the session, whereas CTOP also affected initiation. In Wistar rats, naltrindole microinjections into both the nucleus accumbens and basolateral amygdala decreased ethanol responding, whereas CTOP was effective only in the amygdala. Injections of these antagonists into the ventral tegmental area had little effect on ethanol intake.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> The results confirm previous results which showed that both \u03bc\u2010 and \u03b4\u2010opioid receptors are involved in the regulation of ethanol self\u2010administration and indicate that genetic differences between AA and Wistar rats produced by selection do not modify the effects of opioid antagonists. The nucleus accumbens and the basolateral amygdala may be important central sites for the mediation of their suppressive effects.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2001.tb02123.x","type":"journal-article","created":{"date-parts":[[2006,4,11]],"date-time":"2006-04-11T10:15:52Z","timestamp":1144750552000},"page":"25-33","source":"Crossref","is-referenced-by-count":122,"title":["Suppression of Ethanol Responding by Centrally Administered CTOP and Naltrindole in AA and Wistar Rats"],"prefix":"10.1111","volume":"25","author":[{"given":"Petri","family":"Hyyti\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalervo","family":"Kiianmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,11]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90809-V"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(94)90074-4"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00607-R"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00444692"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90309-B"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04082.x"},{"key":"e_1_2_1_8_1","first-page":"2729","article-title":"Heterogeneity and properties of opiate receptors","volume":"40","author":"Chang KJ","year":"1981","journal-title":"Fed Proc"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90142-0"},{"key":"e_1_2_1_10_1","first-page":"518","article-title":"Distribution of the \u03bc and \u0394 opioid binding sites in the brain of the alcohol\u2010preferring AA and alcohol\u2010avoiding ANA lines of rats","volume":"275","author":"Waele J\u2010P","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_11_1","first-page":"788","article-title":"The alcohol\u2010preferring C57BL\/6 mice present an enhanced sensitivity of the hypothalamic \u03b2\u2010endorphin system to ethanol than the alcohol\u2010avoiding DBA\/2 mice","volume":"261","author":"Waele J\u2010P","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_12_1","first-page":"1236","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies","volume":"266","author":"Devine DP","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_13_1","first-page":"725","article-title":"Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic [D\u2010Penicillamine2\u2010D\u2010Penicillamine5]enkephalin in the rat","volume":"259","author":"Drower EJ","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.159.3816.739"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90145-E"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244246"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(94)90083-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(89)90167-7"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1992.tb01399.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-24-10663.1998"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050169"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04669.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00118-5"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90527-Z"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051145"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050156"},{"key":"e_1_2_1_27_1","first-page":"544","article-title":"Novel peptidic mu opioid antagonists: Pharmacologic characterization in vitro and in vivo","volume":"249","author":"Kramer TH","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246191"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)00080-G"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00474-7"},{"key":"e_1_2_1_31_1","first-page":"16A","article-title":"Effects of intracranial injections of selective opioid receptor agonists and antagonists on alcohol consumption","volume":"23","author":"L\u00ea AD","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(95)93946-U"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00517-8"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00679-9"},{"key":"e_1_2_1_35_1","first-page":"16A","article-title":"Infusion of a delta opioid receptor antagonist into the VTA produces early termination of alcohol drinking in P rats given scheduled access to alcohol","volume":"23","author":"McCullough DE","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1994.tb00118.x"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209532200"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00161a037"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90106-X"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90502-X"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00539-8"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1986.tb05120.x"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(92)90045-C"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(97)00125-0"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(97)00131-6"},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1523\/JNEUROSCI.18-05-01923.1998","article-title":"Cellular sites for activation of \u0394\u2010opioid receptors in the rat nucleus accumbens shell: Relationship with Met5\u2010enkephalin","volume":"18","author":"Svingos AL","year":"1998","journal-title":"J Neurosci"},{"key":"e_1_2_1_47_1","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1523\/JNEUROSCI.17-07-02585.1997","article-title":"\u03bc\u2010opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens","volume":"17","author":"Svingos AL","year":"1997","journal-title":"J Neurosci"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2001.tb02123.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2001.tb02123.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:52:37Z","timestamp":1700293957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2001.tb02123.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1111\/j.1530-0277.2001.tb02123.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2001.tb02123.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}